Conjugation, labelling and in vitro/in vivo assessment of an anti-VEGF monoclonal antibody labelled with niobium isotopes
Niobium-90 (90Nb) is a positron emitting radionuclide that exhibits attractive characteristics for use in the design and synthesis of radioimmunoconjugates. In the current study we have investigated 90Nb as a possible future isotope for immuno-PET. Prior to 90Nb in vivo studies, this paper describes...
Prif Awduron: | De La Fuente, A, Radchenko, V, Tsotakos, T, Tsoukalas, C, Paravatou-Petsotas, M, Harris, AL, Köster, U, Rösch, F, Bouziotis, P |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
Springer Nature
2018
|
Eitemau Tebyg
-
Labeling and preliminary in vivo assessment of niobium-labeled radioactive species: A proof-of-concept study
gan: Radchenko, V, et al.
Cyhoeddwyd: (2016) -
Kit formulation of Bevacizumab, an anti-VEGF monoclonal antibody, and consequent labelling with Rhenium-188: initial in vitro and in vivo studies
gan: Bouziotis, P, et al.
Cyhoeddwyd: (2008) -
Preliminary Evaluation of Iron Oxide Nanoparticles Radiolabeled with <sup>68</sup>Ga and <sup>177</sup>Lu as Potential Theranostic Agents
gan: Evangelia-Alexandra Salvanou, et al.
Cyhoeddwyd: (2022-07-01) -
A novel metal-based imaging probe for targeted dual-modality SPECT/MR imaging of angiogenesis
gan: Tsoukalas, C, et al.
Cyhoeddwyd: (2018) -
Labeling of DOTA-conjugated HPMA-based polymers with trivalent metallic radionuclides for molecular imaging
gan: Elisabeth Eppard, et al.
Cyhoeddwyd: (2018-02-01)